The HIV protease inhibitor indinavir reduces immature dendritic cell transendothelial migration.
Indinavir (IDV) is a protease inhibitor that successfully suppresses HIV-1 replication as part of anti-retroviral therapy. There is evidence to suggest that IDV may also act non-specifically upon host proteases. In this study we investigated whether IDV could modulate protease-dependent molecules in...
Main Authors: | Whelan, K, Lin, C, Cella, M, Mcmichael, A, Austyn, J, Rowland-Jones, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2003
|
Similar Items
-
A rodent model of HIV protease inhibitor indinavir induced peripheral neuropathy
by: Huang, W, et al.
Published: (2016) -
Pharmacokinetic and metabolic effects of American ginseng (<it>Panax quinquefolius</it>) in healthy volunteers receiving the HIV protease inhibitor indinavir
by: Flexner Charles W, et al.
Published: (2008-08-01) -
Nipah Virus Infection of Immature Dendritic Cells Increases Its Transendothelial Migration Across Human Brain Microvascular Endothelial Cells
by: Tiong, Vunjia, et al.
Published: (2018) -
Nipah Virus Infection of Immature Dendritic Cells Increases Its Transendothelial Migration Across Human Brain Microvascular Endothelial Cells
by: Vunjia Tiong, et al.
Published: (2018-11-01) -
Efficient Transendothelial Migration of Latently HIV-1-Infected Cells
by: Reou Tanabe, et al.
Published: (2021-08-01)